Maternal and placental responses before preterm birth: adaptations to increase fetal thyroid hormone availability?

Abstract Background: During pregnancy, maternal thyroid hormone supply is crucial for fetal development. Preterm infants often present with hypothyroxinemia. Preterm birth, either spontaneous or medically indicated, is always the result of a complicated pregnancy. We hypothesized that in preterm birth, the maternal transplacental thyroid hormone supply is influenced by the pregnancy complication and we questioned whether maternal and placental compensatory mechanisms are activated to increase thyroid hormone transfer. Methods: Observational case-control study in mother–infant-dyads with complicated pregnancies ending in spontaneous preterm birth (n = 31) or indicated preterm birth due to vascular complications (n = 45) and normal pregnancies (healthy term controls; n = 41). At delivery, maternal and cord blood and placenta samples were collected. Cord and maternal plasma concentrations of thyroid stimulating hormone (TSH), total T4, fT4/FTI, total T3, and T4 binding globulin (TBG), and maternal serum concentrations of thyroid peroxidase (TPO)-antibodies were measured. Placental maturity was evaluated histologically and mRNA and/or protein levels of thyroid hormone deiodinases (DiO) 1, 2 and 3, and transporters (MCT8, MCT10, and OATP1c1) were quantified. Results: In indicated and spontaneous preterm births, cord plasma T4 concentrations were lower than in healthy term controls (p ≤ .001), whereas T3 was only decreased in spontaneous preterm birth (p ≤ .001). Compared with spontaneous preterm births and healthy term controls, indicated preterm birth was characterized by higher maternal plasma TSH (p ≤ .05), earlier placental maturation, higher placental DiO2 gene and MCT10 protein levels and lower DiO3 gene levels (all p ≤ .01). Conclusions: Low T4 was observed in preterm infants irrespective of the cause of preterm birth, while maternal (TSH) and placental (DiO2, DiO3, and MCT10) compensatory responses were only activated in indicated preterm birth due to vascular complications. This may have mediated the normal fetal T3 availability in preterm infants born after indicated preterm birth but not after spontaneous preterm birth.

[1]  J. Rotteveel,et al.  No Association Between Transient Hypothyroxinemia of Prematurity and Neurodevelopmental Outcome in Young Adulthood. , 2015, The Journal of clinical endocrinology and metabolism.

[2]  Chie-Pein Chen,et al.  Biological Functions of Thyroid Hormone in Placenta , 2015, International journal of molecular sciences.

[3]  G. Macones,et al.  Spontaneous and indicated preterm birth subtypes: interobserver agreement and accuracy of classification. , 2014, American journal of obstetrics and gynecology.

[4]  Yu-qin Yan,et al.  Expression of Organic Anion Transporting Polypeptide 1c1 and Monocarboxylate Transporter 8 in the Rat Placental Barrier and the Compensatory Response to Thyroid Dysfunction , 2014, PloS one.

[5]  Deanne K. Thompson,et al.  Free Thyroxine Levels After Very Preterm Birth and Neurodevelopmental Outcomes at Age 7 Years , 2014, Pediatrics.

[6]  N. Paneth,et al.  Clinical importance of hypothyroxinemia in the preterm infant and a discussion of treatment concerns , 2012, Current opinion in pediatrics.

[7]  S. Mandel,et al.  2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. , 2011, Thyroid : official journal of the American Thyroid Association.

[8]  R. Baergen,et al.  Syncytial Knots as a Reflection of Placental Maturity: Reference Values for 20 to 40 Weeks' Gestational Age , 2010, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[9]  J. Franklyn,et al.  Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction. , 2010, Placenta.

[10]  D. Fisher.  Thyroid system immaturities in very low birth weight premature infants. , 2008, Seminars in perinatology.

[11]  G. Williams,et al.  Neurodevelopmental and Neurophysiological Actions of Thyroid Hormone , 2008, Journal of neuroendocrinology.

[12]  T. Visser,et al.  Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. , 2008, Molecular endocrinology.

[13]  Roberto Romero,et al.  Epidemiology and causes of preterm birth , 2008, The Lancet.

[14]  C. Loo.  Manual of Benirschke and Kaufmann’s Pathology of the Human Placenta , 2006 .

[15]  Fiona L. R. Williams,et al.  Serum thyroid hormones in preterm infants: associations with postnatal illnesses and drug usage. , 2005, The Journal of clinical endocrinology and metabolism.

[16]  Ilse Vanhorebeek,et al.  Intensive insulin therapy protects the endothelium of critically ill patients. , 2005, The Journal of clinical investigation.

[17]  J. Franklyn,et al.  The in vitro effects of triiodothyronine on epidermal growth factor-induced trophoblast function. , 2005, The Journal of clinical endocrinology and metabolism.

[18]  N. Murphy,et al.  Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. , 2004, The Journal of clinical endocrinology and metabolism.

[19]  M. Obregon,et al.  Role of thyroid hormone during early brain development. , 2004, European journal of endocrinology.

[20]  J. Franklyn,et al.  Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies. , 2003, The Journal of clinical endocrinology and metabolism.

[21]  T. Visser,et al.  Regulation of iodothyronine deiodinases in the Pax8-/- mouse model of congenital hypothyroidism. , 2003, Endocrinology.

[22]  E. Jauniaux,et al.  Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. , 2002, The Journal of clinical endocrinology and metabolism.

[23]  L. Burmeister,et al.  Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. , 1997, Endocrinology.

[24]  J. Harney,et al.  Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. , 1996, Endocrinology.

[25]  T. Visser,et al.  Type II and type III deiodinase activity in human placenta as a function of gestational age. , 1996, The Journal of clinical endocrinology and metabolism.

[26]  J. Pinto-Martin,et al.  The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. , 1996, The New England journal of medicine.

[27]  M. Berry,et al.  Type 3 lodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme. , 1995, The Journal of clinical investigation.

[28]  D. Jurkovic,et al.  Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. , 1993, The Journal of clinical endocrinology and metabolism.

[29]  the Swiss Neonatal Network.  The CRIB (clinical risk index for babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units , 1993, The Lancet.

[30]  A. Lennon,et al.  Induction of type III deiodinase activity in astroglial cells by thyroid hormones. , 1992, Endocrinology.

[31]  R. Brand,et al.  Transient hypothyroxinaemia associated with developmental delay in very preterm infants. , 1992, Archives of disease in childhood.

[32]  T. Lao,et al.  Neonatal thyrotrophin and mode of delivery , 1989, British journal of obstetrics and gynaecology.

[33]  J. D. Vijlder,et al.  Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. , 1989, The New England journal of medicine.

[34]  M. Kaplan,et al.  Characteristics of thyroxine 5'-deiodination in cultured human placental cells. Regulation by iodothyronines. , 1985, The Journal of clinical investigation.

[35]  P. Larsen,et al.  Acute posttranscriptional regulation of cerebrocortical and pituitary iodothyronine 5'-deiodinases by thyroid hormone. , 1984, Endocrinology.

[36]  P. Larsen,et al.  Evidence for two pathways of iodothyronine 5'-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism. , 1983, The Journal of clinical investigation.

[37]  P. Larsen,et al.  Thyroxine 5'-deiodinase activity in brown adipose tissue. , 1983, Endocrinology.

[38]  D. Fisher,et al.  Acute release of thyrotropin in the newborn. , 1969, The Journal of clinical investigation.

[39]  S. Werner,et al.  In vivo deiodination of labeled L-thyroxine to L-3,5,3'-triiodothyronine in mouse and human pituitaries. , 1963, The Journal of clinical endocrinology and metabolism.

[40]  R. Negro,et al.  2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. , 2011, Thyroid : official journal of the American Thyroid Association.

[41]  M. Kilby,et al.  The role of the placenta in thyroid hormone delivery to the fetus , 2009, Nature Clinical Practice Endocrinology &Metabolism.

[42]  J. Haddow,et al.  Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. , 2006, Obstetrics and gynecology.

[43]  N. Otsu.  A threshold selection method from gray level histograms , 1979 .